Zydus Lifesciences Receives FinalUsfda Approval For Pemetrexed AChemotherapy Drug

Pemetrexed Is Used To Treat Certain Types Of Cancers, Such As Lung Cancer And Mesothelioma. It Is A Chemotherapy Drug That Works By Slowing Or Stopping The Growth Of Cancer Cells.Zydus Lifesciences Ltd. Has Received Final Approval From The United States Food And Drug Administration (Us Fda) To Market Pemetrexed A Chemotherapy Drug That Works By Slowing Or Stopping The Growth Of Cancer Cells In The Strengths Of 100 Mg Vial, 500 Mg Vial, And 1000 Mg Vial Singledose Vials (Usrld: Alimta). Pemetrexed Is Used To Treat Certain Types Of Cancers, Such As Lung Cancer And Mesothelioma. The Drug Will Be Manufactured At Zydus Hospira. As Per Iqvia Mat March'22), Pemetrexed For Injection Has A Market Size Of $ 1,236 Mn The Group Now Has 314 Approvals And Has So Far Filed Over 400 Andas Since The Commencement Of The Filing Process In Fy 2003-04.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!